Partnership Opportunities in Drug Delivery (PODD) is back in person. In keeping with a proud, decade-long tradition, it combines cutting-edge business and scientific content from the drug delivery field with top-notch speakers.
Going to PODD?
Pharma, biotech and the drug delivery players are gathering to assess delivery needs, the latest trends and deals, and to learn about a wide range of innovative drug delivery technologies.
Insights will encompass proteins, peptides, oligonucleotides, biologics, small molecules and more. PODD provides business development opportunities through organized networking and a partnering tool for new, emerging and established collaborations.
Cambridge Consultants Harshal Shah, head of oncology innovations for global medical technology will be presenting a live in person talk on how miniature active implants are key area for innovation in next-generation drug delivery.
Miniature active implants – the key area for innovation in next-generation drug delivery
Innovation in drug delivery devices has evolved at a constant pace for 30 years, improving outcomes with better delivery of lifesaving drugs. Now, we’re entering a new era – as we look forward to a decade of innovation and commercial opportunity in active implants.
Date | 29 October 2021
Time | 2:50pm - 3:10pm EDT / 7:50pm - 8:10pm
Track | Advancing Next-Generation Device Technologies
Speaker | Harshal Shah, Head of Oncology Innovations, Global Medical Technology
Speaker Bio | Harshal is part of our global medical division based out of Boston, with more than a decade of experience in medical device development, product life cycle strategy, and innovation management. He has significant expertise in oncology patient journey, economics of cancer care and innovations in oncology. He has a Bachelor of Mechanical Engineering degree from Nirma Institute of Technology in India, an MBA from Syracuse University, New York, and he recently completed a post graduate program in cancer biology and therapeutics development from Harvard Medical School.
Related Content
- Engineering the future of innovations in oncology [Whitepaper]
- Drug delivery to the eye: overcoming the challenges of intravitreal prefilled syringes [Insights]
- Our four iF DESIGN AWARDS put us in the top three nationally [Insights]
